Precutting endoscopic band ligation-assisted resection versus endoscopic submucosal dissection in patients with small gastric submucosal tumors originating from the muscularis propria: study protocol of a randomized controlled trial

• Published in: Current controlled trials in cardiovascular medicine Vol. 25; no. 1; pp. 49 - 8
• Main Authors: Liu, Mingfeng, Yuan, Rui, Zhan, Ke, Yang, Yichun, Li, Shan, Deng, Liang
• Format: Journal Article
• Language: English
• Published: London BioMed Central 13.01.2024; BioMed Central Ltd; BMC
• Subjects: Biomedicine; Care and treatment; Clinical trials; Diagnosis; Endoscopic Mucosal Resection - adverse effects; Endoscopy; ESD; Evaluation; Gastrointestinal tumors; GISTs; Health Sciences; Hematemesis; Hospitalization; Humans; Informed consent; Ligation; Medicine; Medicine & Public Health; Pathology; Patients; Precutting EBLR; Randomized controlled trial; Randomized Controlled Trials as Topic; SMT-MPs; SMTs; Statistics for Life Sciences; Stomach Neoplasms - pathology; Stomach Neoplasms - surgery; Study Protocol; Surgery; Surveillance; Treatment Outcome; Tumors; China; SMT-MPs; GISTs; Randomized controlled trial; Precutting EBLR; ESD; SMTs
• ISSN: 1745-6215; 1745-6215
• DOI: 10.1186/s13063-024-07902-7

Background The management of small gastric submucosal tumors (SMTs) originating from the muscularis propria layer (SMT-MPs) remains a subject of debate. Endoscopic submucosal dissection (ESD) is currently considered the optimal treatment for resection. However, high expenses, complex procedures, and the risk of complications have limited its application. Our previously proposed novel operation, precutting endoscopic band ligation (precutting EBL), has been demonstrated in a long-term, single-arm study to be an effective and safe technique for removing small gastric SMTs. However, the absence of a pathological examination and the potential for delayed perforation have raised concerns. Thus, we modified the precutting EBL by adding endoscopic resection to the snare after ligation and closure, yielding the precutting endoscopic band ligation-assisted resection (precutting EBLR). Moreover, the initial pilot study confirmed the safety and efficacy of the proposed approach and we planned a randomized controlled trial (RCT) to further validate its clinical feasibility. Methods This was a prospective, single-center, open-label, parallel group, and randomized controlled trial. Approximately 40 patients with SMT-MPs will be included in this trial. The patients included were allocated to two groups: ESD and precutting EBLR. The basic clinical data of the patients were collected in detail. To better quantify the difference between ESD and precutting EBLR, the primary outcome was set as the operation duration. The secondary outcomes included total operation cost and hospitalization, intraoperative adverse events, and postoperative recurrence. The primary outcome was tested for superiority, while the secondary outcomes were tested for noninferiority. SPSS is commonly used for statistical analysis. Discussion This study was designed to validate the feasibility of a novel operation for removing gastric SMT-MPs. To intuitively assess this phenomenon, the operation durations of precutting EBLR and ESD were compared, and other outcomes were also recorded comprehensively. Trial registration Chinese Clinical Trial Registry ChiCTR2200065473 . Registered on November 5, 2022.